Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1991 | 06-1991 | 03-1991 | 12-1990 | 09-1990 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 490 | 694 | 708 | 729 | 1,296 |
| Marketable Securities | 398 | 398 | 0 | 0 | 0 |
| Receivables | 599 | 558 | 402 | 585 | 243 |
| Other current assets | 72 | 131 | 58 | 160 | 294 |
| TOTAL | $1,559 | $1,780 | $1,168 | $1,474 | $1,833 |
| Non-Current Assets | |||||
| Investments And Advances | 609 | 764 | 1,703 | 1,635 | 1,144 |
| Other Non-Current Assets | 1,501 | 1,510 | 683 | 661 | 650 |
| TOTAL | $2,111 | $2,273 | $2,386 | $2,296 | $1,794 |
| Total Assets | $4,046 | $4,499 | $3,873 | $4,101 | $3,976 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 430 | 458 | 335 | 258 | 181 |
| Accrued Expenses | 452 | 430 | 314 | 207 | 322 |
| TOTAL | $1,008 | $1,026 | $654 | $648 | $684 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 622 | 677 | 205 | 1,159 | 1,271 |
| TOTAL | $622 | $677 | $205 | $1,159 | $1,271 |
| Total Liabilities | $1,270 | $1,288 | $654 | $1,609 | $1,620 |
| Shareholders' Equity | |||||
| Common Shares | 52 | 52 | 52 | 50 | 50 |
| Retained earnings | -16,960 | -16,556 | -15,882 | -16,385 | -15,847 |
| Other shareholders' equity | -77 | -98 | 280 | 427 | 373 |
| TOTAL | $2,416 | $2,797 | $3,014 | $2,293 | $2,021 |
| Total Liabilities And Equity | $3,687 | $4,086 | $3,668 | $3,902 | $3,641 |